Clinical Trial Update: Effects of Ulinastatin on Coagulation in High Risk Patients Undergoing Off Pump Coronary Artery Bypass Graft Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigated the effects of ulinastatin on coagulation in high-risk patients undergoing off-pump CABG; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Ulinastatin (ulinastatin)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Occlusive Disease | Phase 4 | Status: COMPLETED